Market Place
Sourcing Support
Roche Inaugurates Research Home for Institute of Human Biology
23 Mar 2026 //
GLOBENEWSWIRE
NIPER Raebareli, Roche Partner to Boost Drug Research
23 Mar 2026 //
EXPRESSPHARMA
Genentech Drug Fails Rare Disease Trial, Raises Obesity Risk
20 Mar 2026 //
FIERCE BIOTECH
Roche Halts SMA Drug, Boosting Rivals` Prospects
20 Mar 2026 //
BIOSPACE
Mankind Pharma Acquires Rivotril Brand in India
20 Mar 2026 //
INDPHARMAPOST
Genentech Shreds RIPK1 Inhibitor After Ph. 2 Failure
19 Mar 2026 //
FIERCE BIOTECH
Roche Launches NVIDIA AI Factory for Therapeutics, Diagnostics
17 Mar 2026 //
GLOBENEWSWIRE
Bayer Found To Have Discredited Industry After Roche Row
13 Mar 2026 //
FIERCE PHARMA
Roche India Partners With Punjab Govt For `Neurosakhi` Launch
12 Mar 2026 //
EXPRESSPHARMA
Lilly Pledges $500M To South Korea Biopharma Industry
10 Mar 2026 //
FIERCE BIOTECH
Roche`s 2026 Annual General Meeting
10 Mar 2026 //
GLOBENEWSWIRE
Roche`s Oral SERD Flunks 1St-Line Breast Cancer Phase 3
10 Mar 2026 //
FIERCE BIOTECH
Roche Expands Global Trials With $480M+ Commitment In South Korea
05 Mar 2026 //
BIOSPACE
Genentech Announces Positive Phase II Results for Petrelintide
05 Mar 2026 //
PHARMIWEB
Roche Pumps $480M Into South Korea Biopharma Industry
04 Mar 2026 //
FIERCE BIOTECH
North Carolina Attracts Amgen, Roche For Next-Gen Obesity Drug
03 Mar 2026 //
BIOSPACE
Emcure Partners with Roche on Nephrology, Transplant Care
03 Mar 2026 //
INDPHARMAPOST
Roche`s Fenebrutinib Validates First BTK Inhibitor For MS
03 Mar 2026 //
GLOBENEWSWIRE
Signatera MRD Data at ASCO GU Support Use Across GU Cancers
27 Feb 2026 //
BUSINESSWIRE
Volta Labs Launches New Products, Partnerships at AGBT 2026
26 Feb 2026 //
PR NEWSWIRE
Another Setback For Enspryng As Roche Halts Duchenne Development
23 Feb 2026 //
FIERCE PHARMA
FDA accepts NDA for Roche’s giredestrant in ESR1-Mutated
23 Feb 2026 //
GLOBENEWSWIRE
FDA Approves Venclexta, Acalabrutinib For Untreated CLL Leukemia
23 Feb 2026 //
PRESS RELEASE
Roche Seeks Partner to Take Over Plant, Produce Key Antibiotic
23 Feb 2026 //
FIERCE PHARMA
Roche`s Lunsumio Approved in Canada
17 Feb 2026 //
HEALTH CANADA
Roche Announces Changes to Enlarged Executive Committee
17 Feb 2026 //
GLOBENEWSWIRE
Roche Announces Positive Phase III Results For Gazyva/Gazyvaro
17 Feb 2026 //
GLOBENEWSWIRE
Roche Unveils Data Behind BTK Inhibitor`s Phase 3 MS Win
09 Feb 2026 //
FIERCE BIOTECH
Delayed Notice Reveals 141 More Layoffs From Genentech In 2025
09 Feb 2026 //
BIOSPACE
Roche`s Fenebrutinib Reduces Disability Progression In Primary
07 Feb 2026 //
GLOBENEWSWIRE
OX40, Roche-Sanegene, Daiichi—Fierce Pharma Asia
06 Feb 2026 //
FIERCE PHARMA
Biogen Bets HD Spinraza Can Outmuscle Roche`s Oral Rival
06 Feb 2026 //
FIERCE PHARMA
Chemometec Enters Letter Of Intent With Roche Diagnostics
04 Feb 2026 //
GLOBENEWSWIRE
Roche Continues RNA Return With $1.7B Deal For Sanegene Drug
03 Feb 2026 //
FIERCE BIOTECH
Roche Reports Strong 2025 Results: 7% Sales Growth
29 Jan 2026 //
GLOBENEWSWIRE
Roche Drops $100M Kiniksa Fibrosis Drug From Ph. 2 Pipeline
29 Jan 2026 //
FIERCE BIOTECH
Roche Eyes Busy 2026 Despite Vabysmo Miss, Tecentriq Flop
29 Jan 2026 //
FIERCE PHARMA
Roche Plans To Go Toe-To-Toe With Novo, Lilly In Obesity
29 Jan 2026 //
BIOSPACE
Roche Obesity Drug Shows 22.5% Weight Loss as Catch up With Lilly
28 Jan 2026 //
REUTERS
Roche Scales Genentech`s NC Obesity Drug Site To $2B
21 Jan 2026 //
FIERCE PHARMA
JPM26, Day 1: Updates From Lilly, Takeda, Novartis And Sofinnova
12 Jan 2026 //
FIERCE BIOTECH
Roche Spends $570M On Another ADC Agreement With China`s Medilink
09 Jan 2026 //
BIOSPACE
Medilink Inks Exclusive Licensing Deal With Roche
08 Jan 2026 //
PR NEWSWIRE
Ollin Eyes Phase 3 After Topping Vabysmo In Early-Stage Trial
08 Jan 2026 //
FIERCE BIOTECH
Roche Commits $100M To Keep Its GLP-1 Structure Sound
06 Jan 2026 //
FIERCE BIOTECH
FDA Approves Roche`s Lunsumio VELO For Subcutaneous Use
22 Dec 2025 //
GLOBENEWSWIRE
Roche CEO Points to Higher Future Drug Prices in Switzerland
20 Dec 2025 //
REUTERS
Caris, Genentech Collaborate on Novel Cancer Targets
16 Dec 2025 //
PR NEWSWIRE
FDA Approves Roche`s ENHERTU for HER2+ Metastatic Breast Cancer
16 Dec 2025 //
PR NEWSWIRE
Roche Launches Next-Gen Cobas 6800/8800 in U.S
16 Dec 2025 //
PR NEWSWIRE
Natera and MEDSIR to Collaborate on the MiRaDoR Trial
12 Dec 2025 //
BUSINESSWIRE
Roche Expands Mass Spectrometry Menu With Antibiotics Monitoring
11 Dec 2025 //
GLOBENEWSWIRE
Genentech`s Giredestrant Cuts Er-Positive Breast Cancer
10 Dec 2025 //
BUSINESSWIRE
Roche Links SERD to 30% Breast Cancer Risk Reduction in Phase 3
10 Dec 2025 //
GLOBENEWSWIRE
Genentech Uncovers `Hidden Gems` In Latest #Msvisibility Drive
09 Dec 2025 //
FIERCE PHARMA
Europe Approves Roche`s Gazyva For Active Lupus Nephritis
09 Dec 2025 //
GLOBENEWSWIRE
Roche Launches CE-Marked PCR Test for Vaginitis
09 Dec 2025 //
GLOBENEWSWIRE
Roche Reveals Lunsumio Data Suggesting Promise In Early Lymphoma
08 Dec 2025 //
GLOBENEWSWIRE
Genentech Reveals Lunsumio Data In Early Lymphoma Treatment Lines
08 Dec 2025 //
BUSINESSWIRE
Roche`s Columvi Combo Demonstrates Long-Term Survival Benefit
08 Dec 2025 //
GLOBENEWSWIRE
